Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,470.60
-0.10 (-0.01%)
Feb 18, 2026, 12:09 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 278.8 billion as of February 17, 2026. Its market cap has increased by 21.98% in one year.
Market Cap
278.80B
Enterprise Value
291.69B
Revenue
88.50B
Ranking
n/a
PE Ratio
32.04
Stock Price
1,470.60
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 278.80B, an increase of 8.51%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 278.80B | 7.78% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 652.41B |
| Glenmark Pharmaceuticals | 575.35B |
| Laurus Labs | 547.09B |
| Ipca Laboratories | 378.43B |
| Ajanta Pharma | 369.39B |
| Gland Pharma | 302.54B |
| Wockhardt | 226.87B |
| Piramal Pharma | 218.64B |